nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Mechanistic Study to Assess Whether Isoproterenol Can Reverse the Negative Chronotropic Effect of Fingolimod
|
Kovarik, John M. |
|
2008 |
48 |
3 |
p. 303-310 |
artikel |
2 |
BookReview: Burzykowoski T, Molenberghs G, Buyse M (Eds.). The Evaluation of Surrogate End Points. New York: Springer; 2005; XXIV; 416 pp.; $ 84.95
|
Kshirsagar, N.A. |
|
2008 |
48 |
3 |
p. 390-391 |
artikel |
3 |
BookReview: Day S. Dictionary for Clinical Trials, 2nd ed. New York: John Wiley & Sons; 2007; 262 pp.; $45.00 paperback, $130.00 hardback
|
|
|
2008 |
48 |
3 |
p. 391-391 |
artikel |
4 |
BookReview: Kallen A. Computational Pharmacokinetics. Boca Raton, FL: Chapman & Hall/CRC Press; 2007; 170 pp.; $79.95
|
|
|
2008 |
48 |
3 |
p. 391-391 |
artikel |
5 |
Books Available for Review
|
|
|
2008 |
48 |
3 |
p. 391-391 |
artikel |
6 |
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
|
Kalliokoski, Annikka |
|
2008 |
48 |
3 |
p. 311-321 |
artikel |
7 |
Effect of Itraconazole on the Pharmacokinetics of Imidafenacin in Healthy Subjects
|
Ohno, Tomoya |
|
2008 |
48 |
3 |
p. 330-334 |
artikel |
8 |
European Medicines Agency (EMEA), Committee for Medicinal Products for Human Use (CHMP). Guideline on the Reporting the Results of Population Pharmacokinetic Analyses. 21 June 2007. (http://www.emea.europa.eu/pdfs/ human/ewp/18599006enfin.pdf)
|
|
|
2008 |
48 |
3 |
p. 389-390 |
artikel |
9 |
From the Editor
|
von Moltke, Lisa L. |
|
2008 |
48 |
3 |
p. 266-266 |
artikel |
10 |
Gui C-H, Li H, Levons J, Lentz K, Gandhi RB, Raghavan K, Smith RL. Predicting effect of food on extent of drug absorption based on physicochemical properties. Pharmaceutical Research. 2007;24:1118-1130
|
|
|
2008 |
48 |
3 |
p. 385-386 |
artikel |
11 |
Letter from the Section Editor
|
|
|
2008 |
48 |
3 |
p. 391-391 |
artikel |
12 |
Malhotra BK, Glue P, Sweeney K, Anziano R, Mancuso J, and Wicker P. Thorough QT study with recommended and supratherapeutic doses of tolterodine. Clinical Pharmacology and Therapeutics. 2007;81:377-385
|
|
|
2008 |
48 |
3 |
p. 386-387 |
artikel |
13 |
Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia
|
Kenney, Christopher |
|
2008 |
48 |
3 |
p. 379-384 |
artikel |
14 |
Pharmacokinetic and Pharmacodynamic Study of the Concomitant Administration of Methadone and TMC125 in HIV-Negative Volunteers
|
Schöller-Gyüre, Monika |
|
2008 |
48 |
3 |
p. 322-329 |
artikel |
15 |
Pharmacokinetics of Glucarpidase in Subjects With Normal and Impaired Renal Function
|
Phillips, Marc |
|
2008 |
48 |
3 |
p. 279-284 |
artikel |
16 |
Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Severe Hepatic Impairment
|
Zimmerman, James J. |
|
2008 |
48 |
3 |
p. 285-292 |
artikel |
17 |
Population Pharmacokinetics of Cetuximab in Patients With Squamous Cell Carcinoma of the Head and Neck
|
Dirks, Nathanael L. |
|
2008 |
48 |
3 |
p. 267-278 |
artikel |
18 |
Prevalence of Platelet Nonresponsiveness to Aspirin in Patients Treated for Secondary Stroke Prophylaxis and in Patients With Recurrent Ischemic Events
|
Gengo, Francis M. |
|
2008 |
48 |
3 |
p. 335-343 |
artikel |
19 |
Ratain MJ, Cohen EE. The value meal: how to save $1700 per month or more on lapatinib. Journal of Clinical Oncology. 2007;25:3397-3398
|
|
|
2008 |
48 |
3 |
p. 388-389 |
artikel |
20 |
Relative Bioavailability of Lisdexamfetamine 70-mg Capsules in Fasted and Fed Healthy Adult Volunteers and in Solution: A Single-Dose, Crossover Pharmacokinetic Study
|
Krishnan, Suma |
|
2008 |
48 |
3 |
p. 293-302 |
artikel |
21 |
Review/DrugMetabolism and Transport: P-glycoprotein: So Many Ways to Turn It On
|
Callaghan, Richard |
|
2008 |
48 |
3 |
p. 365-378 |
artikel |
22 |
Review/Methods: Clinical Microdialysis in Skin and Soft Tissues: An Update
|
Schmidt, Stephan |
|
2008 |
48 |
3 |
p. 351-364 |
artikel |
23 |
Roffey SJ, Obach RS, Gedge JI, Smith DA. What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs. Drug Metabolism Reviews. 2007;39:17-43
|
|
|
2008 |
48 |
3 |
p. 387-387 |
artikel |
24 |
Schachter AD, Ramoni MF. Paediatric drug development. Nature Reviews Drug Discovery. 2007;6:429-430
|
|
|
2008 |
48 |
3 |
p. 388-388 |
artikel |
25 |
TherapeuticReview: The Basis of an Intracrine Pharmacology
|
Re, Richard N. |
|
2008 |
48 |
3 |
p. 344-350 |
artikel |
26 |
van der Bol JM, Mathijssen RHJ, Loos WJ, et al. Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. Journal of Clinical Oncology. 2007;25:2719-2726. Commentary by Benowitz NL. Cigarette smoking and the personalization of irinotecan therapy. Journal of Clinical Oncology. 2007;25:2646-2647
|
|
|
2008 |
48 |
3 |
p. 388-388 |
artikel |